Assessing Toxicokinetic Uncertainty and Variability in Risk Prioritization
- 18 September 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 172 (2), 235-251
- https://doi.org/10.1093/toxsci/kfz205
Abstract
High(er) throughput toxicokinetics (HTTK) encompasses in vitro measures of key determinants of chemical toxicokinetics and reverse dosimetry approaches for in vitro-in vivo extrapolation (IVIVE). With HTTK, the bioactivity identified by any in vitro assay can be converted to human equivalent doses and compared with chemical intake estimates. Biological variability in HTTK has been previously considered, but the relative impact of measurement uncertainty has not. Bayesian methods were developed to provide chemical-specific uncertainty estimates for 2 in vitro toxicokinetic parameters: unbound fraction in plasma (fup) and intrinsic hepatic clearance (Clint). New experimental measurements of fup and Clint are reported for 418 and 467 chemicals, respectively. These data raise the HTTK chemical coverage of the ToxCast Phase I and II libraries to 57%. Although the standard protocol for Clint was followed, a revised protocol for fup measured unbound chemical at 10%, 30%, and 100% of physiologic plasma protein concentrations, allowing estimation of protein binding affinity. This protocol reduced the occurrence of chemicals with fup too low to measure from 44% to 9.1%. Uncertainty in fup was also reduced, with the median coefficient of variation dropping from 0.4 to 0.1. Monte Carlo simulation was used to propagate both measurement uncertainty and biological variability into IVIVE. The uncertainty propagation techniques used here also allow incorporation of other sources of uncertainty such as in silico predictors of HTTK parameters. These methods have the potential to inform risk-based prioritization based on the relationship between in vitro bioactivities and exposures.Keywords
Funding Information
- Oak Ridge Institute for Science and Education
This publication has 75 references indexed in Scilit:
- Dose metric considerations in in vitro assays to improve quantitative in vitro–in vivo dose extrapolationsToxicology, 2015
- Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven FrameworkToxicological Sciences, 2013
- Improving the Human Hazard Characterization of Chemicals: A Tox21 UpdateEnvironmental Health Perspectives, 2013
- Evaluation of Biomonitoring Data from the CDC National Exposure Report in a Risk Assessment Context: Perspectives across ChemicalsEnvironmental Health Perspectives, 2013
- Addressing Human Variability in Next-Generation Human Health Risk Assessments of Environmental ChemicalsEnvironmental Health Perspectives, 2013
- Screening of chemicals for human bioaccumulative potential with a physiologically based toxicokinetic modelArchives of Toxicology, 2011
- In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast ProjectEnvironmental Health Perspectives, 2010
- Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approachToxicology and Applied Pharmacology, 2009
- A Two-Component Model for Measurement Error in Analytical ChemistryTechnometrics, 1995
- The practice of health risk assessment in the united states (1975–1995): How the U.S. and other countries can benefit from that experienceHuman and Ecological Risk Assessment: An International Journal, 1995